Dr Reddy's increases its manufacturing capacity

By Susan Gotensparre

- Last updated on GMT

Dr Reddy's Laboratories has boosted its ability to serve Western
pharmaceutical markets with an increase in its manufacturing
capacity for drug formulations.

Dr Reddy's has invested $100 million to increase its capacity within formulations, active pharmaceutical ingredients (APIs) and custom pharmaceutical services. This will fit in well with the firm's expansion of its manufacturing capacity meant for the EU and US market.

India-based Dr Reddy's has expanded its existing units in Hyderabad and in Vishakaptnam and may open two more in Hyderabad and Srikakulam district of Andhra Pradesh.

To help fund these expansions, Dr Reddy's will use cash raised via a recent placement of American Depository Shares (ADS) that brought in around $250 million.

"The sum will be used for corporate purposes which include geographic expansion, potential acquisitions of, or investments in, companies and technologies that complement our business, capital expenditures for increasing production capacities, addition of new capabilities and so on​," said Mythili Mamidanna, as spokesperson for Dr Reddy's.

The 18-month expansion period will see the company having a robust manufacturing presence in the area. Although, the two new units are still at the planning stage, Dr Reddy's has received in-principle approval from the Indian Government to acquire the necessary land (100 hectares) to qualify as a Special Economic Zone Plan.

Dr Reddy's has 15 sites globally, such as six facilities of active pharmaceutical ingredients Andhra Pradesh, two technology development centers for custom pharmaceutical services (CPS) in India, one CPS in Cuvernavaca, Mexico, six finished dosage units in India and one biologics facility in India.

Related news

Show more

Related products

show more

Roquette Oral Dose Case Study

Roquette Oral Dose Case Study

Roquette Pharma Solutions | 06-Nov-2017 | Case Study

Download the case study and learn more on how Roquette’s taste masking technology KLEPTOSE® Linecaps (KL) allows the delivery of an efficient taste masking...

The Solid Dose, Latest News from Colorcon

The Solid Dose, Latest News from Colorcon

Colorcon Inc. | 06-Nov-2017 | Data Sheet

With a commitment to serve customers through product innovation and technical excellence, Colorcon's Solid Dose newsletter brings you the latest insight...

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Related suppliers